TMCnet News
Global Fatty Liver Disease Drugs Market By Type, Stages of ALD and NAFLD, Region & Country: Opportunities and Forecast (2017-2022) - Research and MarketsThe "Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) " report has been added to Research and Markets' offering. The global market is projected to display a robust growth represented by a CAGR of 22.67% during 2017-2022, chiefly driven by rising prevalence of obesity, diabetes and hypertension, rising clinical trials in Asian countries, heavy investments by government of different countries in their health care sector, rising research in developing the different health care machines and methodology for the detection of alcohol and non-alcohol steatosis at its early stage. Over the recent years, the global fatty liver disease incidence has been growing rapidly with increase in prevalence of obesity, type II diabetes along with rising consumption of alcohol. Globally, the growth in the fatty liver disease market is driven by rising awareness among people by government organizations and private companies, heavy investments by pharmaceutical companies for the development of drugs along with launch of drugs for NASH in the forecaste period. Companies Mentioned
Key Topics Covered: 1. Research Methodology 2. Executive Summary 3. Strategic Recommendation 4. Fatty Liver Market Outlook 5. Global Fatty Liver Disease Market: Growth and Forecast 6. Global Fatty Liver Disease - Analysis By Type 7. Global Alcoholic Fatty Liver Disease Market - Analysis By Stages 8. Global Non Alcoholic Fatty Liver Disease Market- Analysis By Stages 9. Global Alcoholic Fatty Liver Disease Market - Analysis By Drugs 10. Global Non Alcoholic Fatty Liver Disease Market -By Drugs 11. Global Fatty Liver Disease Market - Pipeline Analysis (By developer, Phase and indication) 12. Global Fatty Liver Disease Market - Regional Analysis 13. North America Fatty liver Disease Market- An Analysis 14. North America Fatty Liver Disease Market -By Country Analysis 15. Asia Pacific Fatty liver Disease Market - An Analysis 16. Asia Pacific Fatty Liver Disease Market - By Country Analysis 17. Europe Pacific Fatty liver Disease Market- An Analysis 18. Europe Fatty Liver Disease Market - By Country Analysis 19. Rest of World Fatty liver Disease Market- An Analysis 20. Rest of World Fatty Liver Disease Market - By Country Analysis 21. Market Dynamics 22. Market Trends 23. Policy and Regulations 24. Porter Five Force 25. SWOT Analysis 26. Company Profiles For more information about this report visit https://www.researchandmarkets.com/research/f2skbj/global_fatty View source version on businesswire.com: http://www.businesswire.com/news/home/20170731006322/en/ |
